219 filings
Page 3 of 11
UPLOAD
qguhtqqukgmzz0dj
14 Dec 23
Letter from SEC
12:00am
8-K
gpqe6w7sy
30 Oct 23
Deciphera Pharmaceuticals Announces Third Quarter 2023 Financial Results
7:06am
8-K
l8luim0mj 2n51ay
9 Aug 23
Deciphera Pharmaceuticals Announces Second Quarter 2023 Financial Results
7:06am
8-K
ltk5886e2bf1qjiaxzc
3 Aug 23
Deciphera Pharmaceuticals Announces Retirement of Daniel L. Flynn, Ph.D., and Appointment of
4:20pm
8-K
c88544 bb45gsstqm
22 Jun 23
Submission of Matters to a Vote of Security Holders
4:06pm
S-3ASR
gi9f7r
3 May 23
Automatic shelf registration
8:45am
8-K
mea6uyn21
3 May 23
Deciphera Pharmaceuticals Announces First Quarter 2023 Financial Results
7:07am
ARS
wqvzq6v7byy0wrh
26 Apr 23
Annual report to shareholders
8:14am
DEFA14A
lddx3g91
26 Apr 23
Additional proxy soliciting materials
8:06am
S-8
gtwg g9awt
7 Feb 23
Registration of securities for employees
8:42am
8-K
0iye7ro76
7 Feb 23
Deciphera Pharmaceuticals Announces Fourth Quarter and Full Year 2022 Financial Results
7:14am
8-K
80eymsur
20 Jan 23
Entry into a Material Definitive Agreement
4:05pm
424B5
rrkmu45evpiwfec4yr
20 Jan 23
Prospectus supplement for primary offering
4:02pm
8-K
9l82l
18 Jan 23
Other Events
5:21pm
424B5
oa13xqvafue4ryec9lh
18 Jan 23
Prospectus supplement for primary offering
5:18pm